文献速递眼底病与葡萄膜炎

视网膜积液分区对新生血管性年龄相关性黄斑变性功能结局的影响:系统综述

IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Literature Review.
PubMed 文献 · Retina · 2022-01-01

该系统综述依据Cochrane方法从1797条记录中纳入27项研究,评估持续性或新发视网膜下液、视网膜内液及视网膜下色素上皮液对新生血管性年龄相关性黄斑变性患者1年治疗期间视力 acuity 的影响。结果显示视网膜内液在基线和治疗全程均对视力有负面影响,中心凹视网膜内液比中心凹外影响更差;视网膜下液(尤其中心凹下)部分研究显示与第1年及更长期视力较高相关,另一些研究则提示第1年和第2年不影响视力。视网膜下色素上皮液数据稀缺且未达成共识。

要点

  • 视网膜内液在基线和治疗全程均与较差视力相关,中心凹内液影响大于中心凹外。
  • 视网膜下液(尤其中心凹下)对第1年视力影响的研究结论不一致,部分显示视力较高。
  • 视网膜下色素上皮液对视力影响的数据稀缺,尚无共识。

核心结论

  • 视网膜内液持续负向影响新生血管性年龄相关性黄斑变性患者基线和治疗期间的视力。
  • 视网膜下液(尤其中心凹下)与第1年及更长期视力关系的研究结论存在分歧。
  • 视网膜下色素上皮液对视力影响的数据稀缺且未达成共识,需验证性研究。

研究设计与样本

  • 系统综述,按Cochrane方法进行文献筛选和数据提取。
  • 共筛选1797条记录,最终纳入27项符合条件的研究。

主要发现

  • 视网膜内液在基线和整个治疗期间对视力有负面影响。
  • 中心凹视网膜内液比中心凹外视网膜内液与更低的视力相关。
  • 部分研究显示视网膜下液(尤其中心凹下)与第1年及更长期视力较高相关,另一些研究提示第1年和第2年不影响视力。
  • 关于视网膜下色素上皮液对视力影响的数据稀缺,未达成共识。
  • 很少有研究报告与积液状态相关的注射次数。

临床怎么用

  • 临床管理新生血管性年龄相关性黄斑变性时需理解不同视网膜积液分区对视力 acuity 的影响。
  • 初始治疗后,抗血管内皮生长因子方案可耐受稳定的视网膜下液(若视力稳定或改善),但不应耐受视网膜内液,以助患者达到最佳视力。

局限性

  • 视网膜下色素上皮液相关数据稀缺且未达成共识。
  • 很少有研究报告与积液状态相关的注射次数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Understanding the impact of fluid in different retinal compartments is critical to developing treatment paradigms that optimize visual acuity and reduce treatment burden in neovascular age-related macular degeneration. This systematic review aimed to determine the impact of persistent/new subretinal fluid, intraretinal fluid, and subretinal pigment epithelial fluid on visual acuity over 1 year of treatment. METHODS: Publication eligibility and data extraction were conducted according to Cochrane methods: 27 of the 1,797 screened records were eligible. RESULTS: Intraretinal fluid negatively affected visual acuity at baseline and throughout treatment, with foveal intraretinal fluid associated with lower visual acuity than extrafoveal intraretinal fluid. Some studies found that subretinal fluid (particularly subfoveal) was associated with higher visual acuity at Year 1 and longer term, and others suggested subretinal fluid did not affect visual acuity at Years 1 and 2. Data on the effects of subretinal pigment epithelial fluid were scarce, and consensus was not reached. Few studies reported numbers of injections associated with fluid status. CONCLUSION: To optimally manage neovascular age-related macular degeneration, clinicians should understand the impact of fluid compartments on visual acuity. After initial treatment, antivascular endothelial growth factor regimens that tolerate stable subretinal fluid (if visual acuity is stable/improved) but not intraretinal fluid may enable patients to achieve their best possible visual acuity. Confirmatory studies are required to validate these findings.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Chaudhary V, Matonti F, Zarranz-Ventura J, et al. IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Literature Review. Retina. 2022. PMID: 34393212. doi:10.1097/IAE.0000000000003283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。